We are finalizing the development of SARS-CoV-2 Nucleoprotein. The antigen can be used in serology assays.
We have now developed a recombinant GFAP protein that can be used as a standard or calibrator in GFAP immunoassay development
Insulin-like growth factor binding protein-4 (IGFBP-4) fragments have been shown to predict the risk of major adverse cardiovascular events, including segment-elevation myocardial infarction, in patients with acute coronary syndrome.
We are finalizing the development of SARS-Cov-2 Spike RBD recombinant antigen.
In dogs, C-reactive protein (CRP)
can be used as a marker of inflammation. Its concentration in blood increases
rapidly in systemic inflammation and decreases quickly during recovery. It has
been shown to increase in disorders such as bacterial infections, sepsis and
pyometra, as well as in the case of post-surgical infections.
Prof. Fred S. Apple (Hennepin Healthcare/Hennepin County Medical Center, Laboratory Medicine and Pathology, and University of Minnesota School of Medicine, Minneapolis MN, US) is the winner of the 2020 IFCC Distinguished Award for Contributions to Cardiovascular Diagnostics, sponsored by HyTest. This award honors an individual who has undertaken remarkable scientific work with cardiac markers or immunodiagnostic applications to improve cardiac disease diagnosis.
We will attend the 17th China Association of Clinical Laboratory Practice Expo held at Nanchang Greenland International Expo Center, on 21-23 August.
The cardiac isoform of Troponin I (cTnI) is used as a gold standard as marker of acute myocardial infarction (AMI). The region 24-40 aar of cTnI is a perspective target for monoclonal antibodies (MAb), because it is less affected by the action of autoantibodies and is not hindered by the other components of troponin complex.
By watching this webinar, you will learn about:
- the use of nucleic acid testing and serological testing for diagnostics of COVID-19, as well as the benefits and limitations of these methods for COVID-19 diagnostics
- the effects of SARS-CoV-2 on the cardiovascular system
- the role of cardiac and inflammatory biomarkers in distinguishing the severity and prognosis of COVID-19
The World Health Organization (WHO) declared the Coronavirus outbreak a pandemic on Wednesday, March 11, and we are very closely following the changing situation on a daily basis. We would like to confirm to you that we are continuing to supply our products as normal.
Heart failure is a severe health problem that is characterized by an increasing prevalence and economic cost.
How can we make cancer research, treatment and life with cancer better? Read more and join the contest
HyTest Shanghai has decided to cancel the opening ceremony of the new premises scheduled for the end of February 2020 due to the epidemic situation in China
NGAL (neutrophil gelatinase-associated lipocalin) is a small glycoprotein found in blood and urine. It is expressed by kidney tubular cells after kidney injury and it has been indicated as a promising biomarker of acute kidney injury. In addition, NGAL concentration is known to increase in severe infections.
We provide several mouse and rabbit derived monoclonal antibodies specific to human NGAL. In addition, we have developed a recombinant NGAL protein that can be used as a calibrator or standard in NGAL immunoassays.
Traumatic brain injuries (TBIs), including concussions, are one of the main public health concerns globally. TBI diagnosis is currently based on clinical assessment using scores such as Glasgow coma scale and computer tomography. However, scores can be compromised for various reasons and the computer tomography is less than perfect too as even in severe cases the findings can be normal.
With effect from October 2019, Karen has been the North America Sales Manager of HyTest.
Our researchers wrote an editorial for a Clinical Chemistry article
addressing an important but poorly studied interrelationship between
obesity and natriuretic peptide measurements.
We will be attending Medica 2019 in November.
We are delighted to introduce our latest team member, CCO Juhana Rauramo.